A Review of New Drug Innovation – Emerging Challenges And Mitigation Strategies
Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2014, Vol 4, Issue 1
Abstract
: The present paper reviews trends in the development and approval of new drugs. The pharmaceutical industry continues to face the problems of high costs of new drug development, FDA’s regulatory regime, and competition from generic drugs. At the same time, consumers’ expectations regarding drug efficacy and safety have continued to increase. This explains why it has become increasingly harder for drug firms to invent new molecules during the last three decades. A few of the resolutions to these problems include strategic drug development data generation, lifecycle planning for a new molecular entity and mergers and acquisitions involving biotechnology and pharmaceutical companies. Moreover, cooperation amongst FDA’s review division and industry is not at desired level to seek development of new safety and efficacy models for enhance productivity in the industry..
Authors and Affiliations
Samrat Sisodia
Keywords
Related Articles
- EP ID EP120966
- DOI -
- Views 196
- Downloads 0
[b]HPLC method for Pharmacokinetics of cis and trans isomer of cefprozildiastereomers in human plasma[/b]
Metabolic disturbances in schizophrenia: Association with disease and drugs
Schizophrenia is a chronic and complex psychiatry disorder. Metabolic complications are commonly seen in patients with schizophrenia both in drug naive as well as treatment experienced patients. The disease itsel...
Protective Effect of Andrographis paniculata Against Atrazine Induced Renotoxicity in Albino Rats
Andrographis paniculata is (AP) a medicinal plant that has been effectively used in traditional Asian medicines for centuries. Its major constituents are diterpenoids, flavonoids and polyphenols. The efficiency o...
[b]Synthesis, characterization and evaluation of in vitro antioxidant and anti-inflammatory activity of 2-(4-oxo-2-phenylquinazolin-3(4H)-yl) substituted acetic acids[/b]
In vitro antimicrobial evaluation of Anthocephalus cadamba, Butea monosperma, Diospyrous melanoxylon and Ficus glomerata bark extract against certain bacteria
Anthocephalus cadamba, Butea monosperma, Diospyrous melanoxylon and Ficus glomerata bark are used for the preparation of ethnic skin ointments. This ointment in turn is deployed over wounds for healing purposes and to ch...